文献速递肝病

血氨水平不能指导肝硬化肝性脑病的临床管理

Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis.
PubMed 文献 · Am J Gastroenterol · 2020-01-01

该研究纳入2005至2015年因肝性脑病住院的肝硬化患者,分析血氨水平与乳果糖治疗强度的关系。结果显示,无论是否检测血氨或血氨是否升高,48小时内乳果糖总剂量无显著差异,且乳果糖剂量与血氨水平无相关性,提示血氨水平并未指导临床治疗。

要点

  • 血氨检测与否及水平高低均未影响肝性脑病患者的乳果糖用量。
  • 升高血氨组与正常血氨组的平均乳果糖剂量相同(161 mL)。
  • 乳果糖剂量与血氨水平无相关性(R=0.0026)。

核心结论

  • 住院肝性脑病患者使用乳果糖的治疗未受血氨检测或血氨水平影响,提示血氨水平在临床实践中不指导治疗。

研究设计与样本

  • 采用倾向性匹配控制基础疾病严重程度混杂,将检测血氨者分为正常与升高两组。

主要发现

  • 551例(46%)检测了血氨,其中328例(60%)血氨异常(>72 μmol/L)。
  • 无血氨组与有血氨组48小时平均乳果糖总剂量分别为167 mL和171 mL(P=0.42)。
  • 血氨升高组平均乳果糖剂量为161 mL,与血氨正常组完全相同。
  • 乳果糖剂量与血氨水平无相关性(R=0.0026)。
  • 有无血氨检测者在Child-Pugh评分、MELD或Charlson合并症指数上无显著差异。

关键数值与推荐

  • 血氨异常定义为>72 μmol/L。
  • 主要终点为肝性脑病管理最初48小时内给予的乳果糖总量(mL)或剂量。

临床怎么用

  • 临床中不应依据血氨水平调整肝性脑病的乳果糖治疗。
  • 血氨检测可能不必要地用于肝性脑病管理决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Ammonia appears to play a major role in the pathophysiology of hepatic encephalopathy (HE), but its role in guiding management is unclear. We aimed to understand the impact of ammonia levels on inpatient HE management, hypothesizing that patients with elevated ammonia levels would receive more aggressive lactulose therapy than patients with normal ammonia or no ammonia level drawn. METHODS: We examined patients with cirrhosis older than 18 years admitted for management of HE from 2005 to 2015. We additionally used propensity matching to control for confounding by the severity of underlying disease. Patients with an ammonia level taken at time of HE diagnosis were further separated into those with normal or elevated ammonia levels. The primary endpoint was the total lactulose (mL) amount (or dose) given in the first 48 hours of HE management. RESULTS: One thousand two hundred two admissions with HE were identified. Ammonia levels were drawn in 551 (46%) patients; 328 patients (60%) had an abnormal ammonia level (>72 μmol/L). There were no significant differences in the Child-Pugh score, MELD, or Charlson Comorbidity Index in those with and without ammonia levels drawn. The average total lactulose dose over 48 hours was 167 and 171 mL in the no ammonia vs ammonia groups, respectively (P = 0.42). The average lactulose dose in patients with an elevated ammonia level was 161 mL, identical to the lactulose dose in patients with a normal ammonia level. There was no correlation between lactulose dose and ammonia level (R = 0.0026). DISCUSSION: Inpatient management of HE with lactulose was not influenced by either the presence or level of ammonia level, suggesting that ammonia levels do not guide therapy in clinical practice.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Haj M, Rockey DC. Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis. Am J Gastroenterol. 2020. PMID: 31658104. doi:10.14309/ajg.0000000000000343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。